AMLODIPINE\OLMESARTAN: 69 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
69
Total FAERS Reports
11 (15.9%)
Deaths Reported
35
Hospitalizations
69
As Primary/Secondary Suspect
3
Life-Threatening
3
Disabilities
First Report: 20110101 · Latest Report: 20250408
What Are the Most Common AMLODIPINE\OLMESARTAN Side Effects?
#1 Most Reported
Hypotension
8 reports (11.6%)
#2 Most Reported
Completed suicide
8 reports (11.6%)
#3 Most Reported
Diarrhoea
7 reports (10.1%)
All AMLODIPINE\OLMESARTAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Completed suicide | 8 | 11.6% | 8 | 1 |
| Hypotension | 8 | 11.6% | 0 | 5 |
| Diarrhoea | 7 | 10.1% | 0 | 4 |
| Hypokalaemia | 5 | 7.3% | 0 | 5 |
| Toxicity to various agents | 5 | 7.3% | 3 | 3 |
Who Reports AMLODIPINE\OLMESARTAN Side Effects? Age & Gender Data
Gender: 45.3% female, 54.7% male. Average age: 64.0 years. Most reports from: US. View detailed demographics →
Is AMLODIPINE\OLMESARTAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 1 | 0 |
| 2017 | 4 | 0 | 3 |
| 2018 | 7 | 2 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 5 | 2 | 3 |
| 2021 | 5 | 3 | 0 |
| 2022 | 3 | 0 | 0 |
| 2023 | 7 | 0 | 2 |
| 2025 | 2 | 0 | 1 |
What Is AMLODIPINE\OLMESARTAN Used For?
| Indication | Reports |
|---|---|
| Hypertension | 29 |
| Product used for unknown indication | 24 |
Official FDA Label for AMLODIPINE\OLMESARTAN
Official prescribing information from the FDA-approved drug label.